A Cyclodiaryliodonium NOX Inhibitor for the Treatment of Pancreatic Cancer via Enzyme‐Activatable Targeted Delivery by Sulfated Glycosaminoglycan Derivatives.
- Resource Type
- Article
- Source
- Advanced Healthcare Materials; 7/6/2023, Vol. 12 Issue 17, p1-13, 13p
- Subject
- Language
- ISSN
- 21922640